Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lodi, R.
Right arrow Articles by Barbiroli, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lodi, R.
Right arrow Articles by Barbiroli, B.
Related Collections
Right arrow MRS
Right arrow All Headache
Right arrow Cluster headache
NEUROLOGY 2006;66:1264-1266
© 2006 American Academy of Neurology
Brief Communications

Study of hypothalamic metabolism in cluster headache by proton MR spectroscopy

R. Lodi, MD, G. Pierangeli, MD, C. Tonon, MD, S. Cevoli, MD, C. Testa, PhD, G. Bivona, MD, F. Magnifico, MD, P. Cortelli, MD, P. Montagna, MD and B. Barbiroli, MD

From the Dipartimento di Medicina Clinica e Biotecnologia Applicata (R.L., C. Tonon., C. Testa, G.B., B.B.), Policlinico S. Orsola-Malpighi, Università di Bologna, Italy; and Dipartimento di Scienze Neurologiche (G.P., S.C., F.M., P.M.), Università di Bologna, Italy.

Address correspondence and reprint requests to Dr. Raffaele Lodi, Dipartimento di Medicina Clinica e Biotecnologia Applicata "D. Campanacci," Università di Bologna, Policlinico S. Orsola, Via Massarenti 9, 40138 Bologna, Italy; e-mail: raffaele.lodi{at}unibo.it

The authors used 1H-MRS to investigate hypothalamic metabolism in 26 patients with cluster headache (CH) and 12 healthy subjects. Hypothalamic N-acetylaspartate/creatine was reduced in patients with CH vs controls (p < 0.01). Dividing the patients into episodic CH outside- and in-cluster periods and chronic CH, the hypothalamic N-acetylaspartate/creatine in all three subgroups of patients was reduced. The reduction of the neuronal marker N-acetylaspartate is consistent with hypothalamic neuronal dysfunction in patients with CH.

Disclosure: The authors report no conflicts of interest.

Received July 26, 2005. Accepted in final form January 16, 2006.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.